Navigation Links
Genetic predisposition increases childhood asthma risk
Date:8/20/2007

Children who carry variations in specific genes that metabolize vehicle emissions are more susceptible to developing asthma, particularly if they live near major roadways, a study led by researchers at the University of Southern California (USC) suggests.

Researchers found that children who carried variations in two genes and lived within 75 meters of a major road were up to nine times more likely to develop asthma than children who lived further away, says Muhammad T. Salam, Ph.D. candidate at the Keck School of Medicine of USC, and the studys lead author. The study will appear in the journal Thorax, and is now available online.

This is one of the first studies to report that children with certain genetic backgrounds are even more susceptible to asthma than if they lived near major roads and did not carry the variations, Salam says. We are working to understand how traffic-related exposures may interact with these genes, leading to asthma development.

Asthma is the most common chronic disease in children, and previous studies have shown that traffic-related pollution near the home increases asthma risk and reduces lung growth, according to USC experts.

Researchers drew upon data from the Childrens Health Study (CHS), a longitudinal study of respiratory health among school-age children in 12 Southern California communities. They compared associations between number of genetic variants and exposure to toxins among more than 3,000 study participants.

Researchers found that high levels of microsomal epoxide hydrolase (EPHX1)an enzyme that metabolizes polyaromatic hydrocarbons (PAH) in vehicle emissionswas associated with an increased risk for lifetime asthma. Children with high EPHX1 levels who also carried variations in glutathione S-transferase P1 (GSTP1) genes were four times more likely to have asthma.

Among children who lived within 75 meters of a major road, those with high EPHX1 activity were three times more likely to have asthma than those with lower activity. Children who carried both variations and lived within 75 meters of a major road were at the highest asthma risk. The results were consistent for current, early and late onset asthma.

"This finding demonstrates the critical role of gene environment interaction in determining disease susceptibility," says David A. Schwartz, M.D., director of the National Institute of Environmental Health Sciences. "The investigators at USC have identified key genetic variations in biological pathways related to PAH metabolism that are associated with the occurrence of asthma in children who live in close proximity to traffic."

Approximately 12 percent of children in the study carried both of the variations and three percent were in the highest risk group based on where they lived. However, there are a number of genes that could be linked with asthma, and researchers are just beginning to study the associations between genes and environmental factors, Salam says.

It is difficult to say that if parents with an asthmatic child move further from busy streets, the child will definitely have fewer symptoms, he explains. All that can be said at this moment is that data from this and other studies show strong evidence that living near heavy traffic increases asthma risks and exacerbates symptoms in children who already have asthma.


'/>"/>
Contact: Meghan Lewit
lewit@usc.edu
323-442-2830
University of Southern California
Source:Eurekalert

Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Crowning glory of 2000!!! Cracking of the genetic code is top of tops
3. Genetic influence in menopause
4. Genetics and cholesterol levels
5. Genetics helps in attacking cancer
6. DNA biochip for genetic screening
7. Genetic disorder related with sleep patterns
8. Genetic innovation
9. Sleepwalking has genetic roots
10. A new genetic label for stroke
11. Genetic tests for cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: